WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6...

39
> WE NEED A MICRO CLIMATE CHANGE

Transcript of WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6...

Page 1: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

> WE NEED A MICRO CLIMATE CHANGE

Page 2: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 3: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 4: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 5: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 6: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 7: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 8: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 9: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 10: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

V1. Canopy Growth 112. Tilray 103. Aurora 64. GW Pharmaceuticals 45. Curaleaf 2,76. Aphria 27. GreenThumb 1,78. Cronos 1,59. MedMen 1,510. Acreage 1,2

BIG 10 = $42B

Page 11: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 12: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 13: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

SUSTAINABLE URBAN DELTA

Page 14: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 15: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 16: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 17: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

12.000 BC 1700 AC 1900 AC 1950 AC 2000 2010 2020 2030

1st waveAgricultural revolution

2nd waveIndustrial revolution

3rd waveTelecom revolution

4th waveIT/Automation revolution

1st waveAgricult. revolution

6th waveMachine learning revolution

5th waveSocial media revolution

7th waveCreative revolution

Creative platforms

energy platforms

information platforms

automation platforms

social platforms

Learning platforms

cultural platforms

Page 18: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 19: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 20: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 21: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 22: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 23: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

V

o Microgreens EASYo Lettuceo Leafy herbso Cannabiso Cucumbero Tomatoo Pepperso Strawberries TOUGH

GROWABILITY OF SPECIES

Page 24: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

> ROOM FOR IMPROVEMENT ON SEVERAL TOPICS

Prof.Dr.Ir. Leo Marcelis, Wageningen UR

Page 25: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 26: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 27: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

Investment € 2,000,000

Interest 3% Turnover € 1,200,000 → Kg / year m² Retail price € / kg

Maintenance % investment 2% COGS* € 420,000 100 2000 € 6.00 € 1,200,000

m² grow area 2000 Gross profit € 780,000

Costs / Opex

Electrical € 36,960 → Kwh per 24H Days Weeks € / Kwh Electrical cost

Maintenance € 40,000 2750 7 48 € 0.04 € 36,960

Investment Invest / m² growarea Misc.* € 360,000

€ 2,000,000 € 1,000 Ebitda € 343,040

Amortisation € 333,333

Interest / dividend € 50,000

Net profit (€ 40,293) Min payback period in years: 6 € 333,333

Current payback based on EBITDA: 5.8 years

Current payback based on Net profit: 6.8 years

*Estimation in % of TO Type kg / year

Salanova 100 Approx.

Basil 44 Approx.

Cilantro 26 Approx.

Herbs 37 Approx.

Cut greens 55 Approx.

Cannabis Approx.

Page 28: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 29: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 30: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 31: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 32: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 33: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 34: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 35: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 36: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 37: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 38: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5
Page 39: WE NEED A MICRO CLIMATE CHANGE · 2019. 4. 30. · V 1. Canopy Growth 11 2. Tilray 10 3. Aurora 6 4. GW Pharmaceuticals 4 5. Curaleaf 2,7 6. Aphria 2 7. GreenThumb 1,7 8. Cronos 1,5

V

[email protected]

www.priva.com

www.sustainableurbandelta.com

www.dutchgreenhousedelta.com

www.farmtechsociety.org

THANK YOU!


CURALEAF INVESTOR’S PRESENTATION · This presentation contains “forward-looking information” and “forward-looking statements” within the meaning of the anadian securities

CURALEAF INVESTOR’S PRESENTATION · This presentation contains “forward-looking information” and “forward-looking statements” within the meaning of the anadian securities

CURALEAF INVESTOR PRESENTATION March 2021

CURALEAF INVESTOR PRESENTATION March 2021

APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS APHRIA … · 2019-04-23 · APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS Page 2 its licence to produce and sell medical cannabis

APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS APHRIA … · 2019-04-23 · APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS Page 2 its licence to produce and sell medical cannabis

FREEHOLD PROPERTIES LAUNCHES SPECIALIZED REAL ESTATE ... · About Curaleaf Holdings Curaleaf Holdings, Inc. is the leading vertically integrated multi-state cannabis operator in the

FREEHOLD PROPERTIES LAUNCHES SPECIALIZED REAL ESTATE ... · About Curaleaf Holdings Curaleaf Holdings, Inc. is the leading vertically integrated multi-state cannabis operator in the

Aphria - Q1 2018 FS [FINAL] · PDF fileMarketable securities 5 80,501,420 87,346,787 ... Capital assets 11 92,358,204 ... Unrealized gain on long-term investments 26 (19,081,556)

Aphria - Q1 2018 FS [FINAL] · PDF fileMarketable securities 5 80,501,420 87,346,787 ... Capital assets 11 92,358,204 ... Unrealized gain on long-term investments 26 (19,081,556)

Tilray, Inc.

Tilray, Inc.

Aphria Inc. · Aphria Inc. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MAY 31, 2020 AND MAY 31, 2019 (Expressed in Canadian Dollars, unless otherwise noted)

Aphria Inc. · Aphria Inc. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MAY 31, 2020 AND MAY 31, 2019 (Expressed in Canadian Dollars, unless otherwise noted)

CURALEAF INVESTOR’S PRESENTATION...2 days ago  · Cannabis-Related Practices or Activities are Illegal Under U.S. Federal Laws uraleaf derives 100% of its revenues from doing business

CURALEAF INVESTOR’S PRESENTATION...2 days ago  · Cannabis-Related Practices or Activities are Illegal Under U.S. Federal Laws uraleaf derives 100% of its revenues from doing business

Tilray Economic Impact 2015

Tilray Economic Impact 2015

Aphria reports strong performance in Q1 2018, including record revenue and grams … · Aphria reports strong performance in Q1 2018, including record revenue and grams sold Lowered

Aphria reports strong performance in Q1 2018, including record revenue and grams … · Aphria reports strong performance in Q1 2018, including record revenue and grams sold Lowered

APHRIA INC. MANAGEMENT’S DISCUSSION ......adult-use cannabis, cannabis-derived extracts, and derivative cannabis products in Canada under the provisions of the Cannabis Act. Aphria

APHRIA INC. MANAGEMENT’S DISCUSSION ......adult-use cannabis, cannabis-derived extracts, and derivative cannabis products in Canada under the provisions of the Cannabis Act. Aphria

CURALEAF INVESTOR’S PRESENTATION · In this presentation, PR Revenue includes revenue from closed acquisitions of Arrow Alternative Care and Grassroots as if they occurred on April

CURALEAF INVESTOR’S PRESENTATION · In this presentation, PR Revenue includes revenue from closed acquisitions of Arrow Alternative Care and Grassroots as if they occurred on April

Aphria 2018 Annual Report - Aphria Inc. | Growing The Future ...Inc., Pure Natures Wellness Inc. (o/a Aphria), Cannan Growers Inc., Broken Coast Cannabis Ltd., and 1974568 Ontario

Aphria 2018 Annual Report - Aphria Inc. | Growing The Future ...Inc., Pure Natures Wellness Inc. (o/a Aphria), Cannan Growers Inc., Broken Coast Cannabis Ltd., and 1974568 Ontario

CURALEAF INVESTOR’S PRESENTATION · 2020. 4. 26. · This presentation contains “forward-looking information” and “forward-looking statements” within the meaning of the

CURALEAF INVESTOR’S PRESENTATION · 2020. 4. 26. · This presentation contains “forward-looking information” and “forward-looking statements” within the meaning of the

Global Leader in Medical Cannabis Created by Aphria ... · Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. Disclaimer ... Vivian Bercovici Managing Director

Global Leader in Medical Cannabis Created by Aphria ... · Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. Disclaimer ... Vivian Bercovici Managing Director

CURALEAF INVESTOR’S PRESENTATION - Upd… · the company’s se urities have not een approved or disapproved y the se urities and ex hange commission or by any state securities

CURALEAF INVESTOR’S PRESENTATION - Upd… · the company’s se urities have not een approved or disapproved y the se urities and ex hange commission or by any state securities

CURALEAF INVESTOR’S PRESENTATIONfilecache.investorroom.com/mr5ir_curaleaf/247... · Cautionary Note Regarding Forward-Looking Statements and Future-Oriented Financial Information

CURALEAF INVESTOR’S PRESENTATIONfilecache.investorroom.com/mr5ir_curaleaf/247... · Cautionary Note Regarding Forward-Looking Statements and Future-Oriented Financial Information

APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS APHRIA ...€¦ · Middle East, and Africa with a focus on building a global cannabis company. The Company’s operations are split

APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS APHRIA ...€¦ · Middle East, and Africa with a focus on building a global cannabis company. The Company’s operations are split

CURALEAF INVESTOR’S PRESENTATION...In this presentation, PR Revenue includes revenue from closed acquisitions of Arrow Alternative Care and Grassroots as if they occurred on April

CURALEAF INVESTOR’S PRESENTATION...In this presentation, PR Revenue includes revenue from closed acquisitions of Arrow Alternative Care and Grassroots as if they occurred on April

Aphria 2018 Financial Statements · position of Aphria Inc. and its subsidiaries as at May 31, 2017 and their financial performance and their cash flows for the year then ended in

Aphria 2018 Financial Statements · position of Aphria Inc. and its subsidiaries as at May 31, 2017 and their financial performance and their cash flows for the year then ended in